Page 11234..10..»

Archive for the ‘Stem Cell Complications’ Category

Europes guardian of stem cells and hopes, real and unrealistic – Daily Times

Thursday, January 23rd, 2020

Poland has emerged as Europes leader in stem cell storage, a billion-dollar global industry that is a key part of a therapy that can treat leukaemias but raises excessive hopes.

Read More...

Mutations in donors’ stem cells may cause problems for cancer patients – Washington University School of Medicine in St. Louis

Thursday, January 16th, 2020

Visit the News Hub Heart problems, graft-versus-host disease are concerns A new study from Washington University School of Medicine in St. Louis suggests that bone marrow or blood stem cells from healthy donors can harbor extremely rare mutations that can cause health problems for the cancer patients who receive them. Such stem cell transplants are important for treating blood cancers, including acute myeloid leukemia

Read More...

Allogeneic Stem Cells Market Expected to Grow with a CAGR of 12% Due to New Product Approvals, 2020-2024 – ResearchAndMarkets.com – Business Wire

Thursday, January 16th, 2020

DUBLIN--(BUSINESS WIRE)--The "Allogeneic Stem Cells Market by Application and Geography - Forecast and Analysis 2020-2024" report has been added to ResearchAndMarkets.com's offering. Global Allogeneic Stem Cells Market: About this market The allogeneic stem cells market analysis considers sales from regenerative therapy and drug discovery and development applications.

Read More...

Role of wearable sensors in the early diagnosis of Graft Versus Host Disease – Medical Device Network

Thursday, January 16th, 2020

]]> Graft-versus-host disease (GvHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the hosts cells as foreign. GvHD is a serious condition with high morbidity and mortality.

Read More...

There is a new player in adult bone healing – Baylor College of Medicine News

Thursday, January 16th, 2020

Adult bone repair relies on the activation of bone stem cells, which still remain poorly characterized. Bone stem cells have been found both in the bone marrow and in the outer layer of tissue, called periosteum, that envelopes the bone.

Read More...

Forty Seven: Buy The Dip In This CD47 Pioneer Ahead Of ASCO GI – Seeking Alpha

Monday, January 13th, 2020

Shares of CD47 front-runner Forty Seven (FTSV) have risen by 120% over the past year and by 525% over the past three months. Currently, this growing biotech firm sports a market capitalization of around $1.75 billion, with management executing quite efficiently on accessing financing in mid December with 4.86 million common shares priced at $35 per share (plus underwriter option) for gross proceeds of around $170 million. Biotech Phoenix, a veteran of the industry who graciously offers insights in our Live Chat from time to time, got me interested in this name when he highlighted the significance of promising clinical data for lead product candidate magrolimab in patients with Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML).

Read More...

Tacitus Therapeutics Launches in Collaboration with Mount Sinai to Develop Stem Cell Therapies for Life-Threatening Diseases – PRNewswire

Friday, January 10th, 2020

NEW YORK, Jan. 9, 2020 /PRNewswire/ -- Tacitus Therapeutics, a clinical-stage company, has launched in collaboration with the Mount Sinai Health System to develop stem cell therapies initially targeting blood cancers and related clotting disorders

Read More...

LEUKOTAC (inolimomab) is available again in France, following the granting of cohort ATU for the treatment of graft-versus-host disease,…

Friday, January 10th, 2020

LEUKOTAC (inolimomab) is available again in France, following the granting of cohort ATU for the treatment of graft-versus-host disease, corticosteroid-resistant or corticosteroid-dependent, with grade II-IV Lyon, FRANCE, January 9, 2020, ElsaLys Biotech announced today that the cATU has been granted by the ANSM and its clinical experts, after evaluation of a dossier containing data on the quality, safety and efficacy of the drug based on its administration in several hundred patients included in clinical trials or treatedvia named patient Temporary Authorization for Use (ATU nominative) until November 2015. This authorization includes the implementation of a reinforced monitoring (defined in the Protocol for Therapeutic Use) of the efficacy and safety data obtained in patients treated within the framework of this cATU.

Read More...

ASH 2019 | The impact of donor clonal hematopoiesis on aGvHD and patient outcomes – AML Global Portal

Friday, January 10th, 2020

The presence of preleukemic mutations in peripheral blood (PB) samples is termed clonal hematopoiesis of indeterminate potential (CHIP). CHIP is defined as the absence of definitive morphologic evidence of hematologic neoplasms, with the presence of a somatic mutation with a variate allele frequency (VAF) of > 2%.

Read More...

The viral Augustinus Bader rich cream has completely changed my skin for the better – Yahoo Lifestyle

Friday, January 10th, 2020

Welcome to Try Before You Buy, a monthly series where we talk about the pricey beauty products and in-office treatments that are getting major buzz and give our honest feedback. This month, our Senior Beauty & Fashion Editor, Pia Velasco, talks about theAugustinus Bader cream that has changed her skin. As a beauty editor, Ive tried hundreds (and maybe even thousands) of skincare products since starting my career seven years ago.

Read More...

Mum’s ‘excruciating’ battle with lifelong disease that requires regular blood transfusions – Nottinghamshire Live

Friday, January 10th, 2020

Daily life can be excruciatingly painful and tiring for a West Bridgford mum suffering with a lifelong inherited blood disease. Oyesola Oni, 37, was born with sickle cell disease and has to have eight pints of blood transfused into her body every six weeks at Nottingham City Hospital.

Read More...

Researchers at Baylor College of Medicine Discover How to Improve Bone Repair – Gilmore Health News

Friday, January 10th, 2020

Researchers at Baylor College of Medicine have discovered a new mechanism that helps maintain and repair bones in adults.

Read More...

For Kaus, getting back on court is next step in recovery – Mankato Free Press

Tuesday, January 7th, 2020

Justin Kaus has officiated thousands of basketball games in the last couple of decades, but on Friday night, in the locker room a few minutes before taking the court at Fitzgerald Gym, his resting heart rate was a rapid 118 beats per minute.

Read More...

Wearable monitoring technology helps nurses avoid waking sleep-deprived patients – ABC News

Tuesday, January 7th, 2020

Updated January 06, 2020 08:30:20 Since being diagnosed with Hodgkin's lymphoma 18 months ago, Aliona Grytsenko has spent much of her time in and out of hospital. When the 22-year-old architecture student developed an infection after having a stem cell transplant, she had to be woken every hour to have her vital signs checked. "It made it really hard to sleep and rest in the midst of having fevers and going through the treatment and side effects themselves.

Read More...

Myelofibrosis Treatment Market To Record Heightened Sales During The Forecast Period 2016 2022 – Market Reports Observer

Monday, December 30th, 2019

Myelofibrosis or osteomyelofibrosis is a myeloproliferative disorder which is characterized by proliferation of abnormal clone of hematopoietic stem cells. Myelofibrosis is a rare type of chronic leukemia which affects the blood forming function of the bone marrow tissue. National Institute of Health (NIH) has listed it as a rare disease as the prevalence of myelofibrosis in UK is as low as 0.5 cases per 100,000 population.

Read More...

This Is How Human Head Transplants Could Be Achieved, According To A Neurosurgeon – IFLScience

Sunday, December 29th, 2019

The idea of transplanting a human head onto another persons body may sound like the stuff of science fiction and thats because it is. But while penning a fictional story about the worlds first cranial exchange, neuroscientist Bruce Mathew came up with an idea that he says could soon become a real-life procedure.

Read More...

Transplanting human heads on to another body possible by 2030 – Samaa News

Sunday, December 29th, 2019

A former neurosurgeon, who worked with the UKs National Health Service, has a surprising prediction for the next decade. He claims human head transplants will become a reality by 2030.

Read More...

Autologous Stem Cell and Non Stem Cell Based Therapies Market to Garner Brimming Revenues by 2023 – Industry Mirror

Sunday, December 29th, 2019

In autologous stem cell and non-stem cell based therapies, an individuals cell is cultured and then re-introduced to the donors body. Used for the treatment of various bone marrow diseases, autologous stem cell and non-stem cell based therapies allows patients to have normal bone marrow, which gets destroyed in chemotherapy. The various diseases that can be treated with the help of autologous stem cell and non-stem cell based therapies include: multiple myeloma, aplastic anemia, non-Hodgkins lymphoma, Parkinsons disease, Hodgkins lymphoma, thalassemia, and diabetes

Read More...

Top Technical Advances of 2019 – The Scientist

Wednesday, December 25th, 2019

Artificial intelligence tackles life science Look under the hood of many of this years headline-making discoveries in biology and youll find machine learning, a tool thats gaining ground in the life sciences thanks to growing computational power and the availability of big datasets needed for training. Among other advances in 2019, researchers reported successfully using machine learning to screen images for signs of cancer or infection by pathogens, and to identify epigenetic markers in blood samples that are associated with vascular complications in people with diabetes.

Read More...

Pike River widow ‘on the up’ after stem cell treatment for cancer – Stuff.co.nz

Wednesday, December 25th, 2019

Pike River widow Anna Osborne is "on the up" and out of hospital in time for Christmas.

Read More...

Page 11234..10..»


2020 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick